Phase 1/2 trial evaluating the effectiveness and safety of dose-adapted Hypofractionated pelvic radiotherapy for Advanced Cervical cancers INeligible for ChemoTherapy (HYACINCT)-Reference-Cited by-同舟云学术

Phase 1/2 trial evaluating the effectiveness and safety of dose-adapted Hypofractionated pelvic radiotherapy for Advanced Cervical cancers INeligible for ChemoTherapy (HYACINCT)

Published:2022-03-14 Issue:6 Volume:61 Page:688-697
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Bacorro Warren¹²³^ORCID,Baldivia Kathleen²³,Dumago Mark²,Bojador Maureen²,Milo Abigail³⁴,Trinidad Celestine Marie³⁵,Mariano Jocelyn³⁶,Gonzalez Gil³⁶,Sy Ortin Teresa²³

Affiliation:

1. The Graduate School, University of Santo Tomas, Manila, Philippines

2. Department of Radiation Oncology, University of Santo Tomas Hospital – Benavides Cancer Institute, Manila, Philippines

3. Gynecologic Oncology Unit, University of Santo Tomas Hospital – Benavides Cancer Institute, Manila, Philippines

4. Department of Radiology, University of Santo Tomas Hospital, Manila, Philippines

5. Department of Anatomic Pathology, University of Santo Tomas Hospital, Manila, Philippines

6. Department of Obstetrics and Gynecology, University of Santo Tomas

Funder

Philippine Council for Health and Research Development

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2022.2048070

Reference42 articles.

1. Cervical cancer [Internet]. World Health Organization. World Health Organization; 2021 [cited 2021 Mar]. [Accessed 5 June 2021]. https://www.who.int/health-topics/cervical-cancer#tab=tab_1

2. Bruni L, Albero G, Serrano B, et al. Human Papillomavirus and Related Diseases Report: WORLD. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2021 [cited 2021 Mar]. https://www.hpvcentre.net/statistics/reports/XWX.pdf/

3. Radiation Therapy Infrastructure and Human Resources in Low- and Middle-Income Countries: Present Status and Projections for 2020

4. Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma

5. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability, validity, and sensitivity testing of the expanded prostate index composite—Filipino version;Asian Journal of Oncology;2024-08-16

2. Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer;JAMA Oncology;2024-06-01

3. Hypofractionated Radiotherapy in Gynecologic Malignancies—A Peek into the Upcoming Evidence;Cancers;2024-01-15

4. Intensity-Modulated Radiation Therapy for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy – an Option or a Must?: A Narrative Review;Cancer Research and Treatment;2024-01-15

5. Cost analysis of three-dimensional radiation therapy versus intensitymodulated chemoradiotherapy for locally advanced cervical cancer in Peruvian citizens;ecancermedicalscience;2023-04-20